Resultados da pesquisa - Ashwin N. Ananthakrishnan

Refinar resultados
  1. 1
    Environmental Triggers for Inflammatory Bowel Disease

    Environmental Triggers for Inflammatory Bowel Disease Por Ashwin N. Ananthakrishnan

    Publicado em 2012
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis

    Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis Por Ashwin N. Ananthakrishnan

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Environmental Risk Factors for Inflammatory Bowel Diseases: A Review

    Environmental Risk Factors for Inflammatory Bowel Diseases: A Review Por Ashwin N. Ananthakrishnan

    Publicado em 2014
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Environmental Hygiene and Risk of Inflammatory Bowel Diseases

    Environmental Hygiene and Risk of Inflammatory Bowel Diseases Por Aurada Cholapranee, Ashwin N. Ananthakrishnan

    Publicado em 2016
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Economic burden and cost-effectiveness of therapies for <i>Clostridiodes difficile</i> infection: a narrative review

    Economic burden and cost-effectiveness of therapies for <i>Clostridiodes difficile</i> infection: a narrative review Por Akshita Gupta, Ashwin N. Ananthakrishnan

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Review article: vitamin D and inflammatory bowel diseases

    Review article: vitamin D and inflammatory bowel diseases Por V. Pratap Mouli, Ashwin N. Ananthakrishnan

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  7. 7
    Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

    Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis Por Nienke Z. Borren, Ashwin N. Ananthakrishnan

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  8. 8
    Epidemiology of Primary and Secondary Liver Cancers

    Epidemiology of Primary and Secondary Liver Cancers Por Ashwin N. Ananthakrishnan, Veena Gogineni, Kia Saeian

    Publicado em 2006
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases

    Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases Por Ashwin N. Ananthakrishnan, Emily L. McGinley

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Pivot to Asia: inflammatory bowel disease burden

    Pivot to Asia: inflammatory bowel disease burden Por Prashant Singh, Ashwin N. Ananthakrishnan, Vineet Ahuja

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Clostridium difficile and inflammatory bowel disease

    Clostridium difficile and inflammatory bowel disease Por Mazen Issa, Ashwin N. Ananthakrishnan, David G. Binion

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  12. 12
    Higher Physician Density is Associated with Lower Incidence of Late-stage Colorectal Cancer

    Higher Physician Density is Associated with Lower Incidence of Late-stage Colorectal Cancer Por Ashwin N. Ananthakrishnan, Raymond G. Hoffmann, Kia Saeian

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis

    Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis Por Ashwin N. Ananthakrishnan, Joshua R. Korzenik, Chin Hur

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Diet in Treatment of Inflammatory Bowel Diseases

    Diet in Treatment of Inflammatory Bowel Diseases Por Alexa N. Sasson, Ashwin N. Ananthakrishnan, Maitreyi Raman

    Publicado em 2019
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  15. 15
    Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis

    Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis Por Ashwin N. Ananthakrishnan, Emily L. McGinley, Kia Saeian

    Publicado em 2008
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Management of Inflammatory Bowel Disease in the Elderly Patient

    Management of Inflammatory Bowel Disease in the Elderly Patient Por Ashwin N. Ananthakrishnan, Tamara Donaldson, Karen Lasch, Vijay Yajnik

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  17. 17
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review

    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review Por Ashwin N. Ananthakrishnan, Geoffrey C. Nguyen, Çharles N. Bernstein

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  18. 18
    Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases

    Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases Por David Cheng, Bharati Kochar, Tianxi Cai, Ashwin N. Ananthakrishnan

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations

    Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations Por Ashwin N. Ananthakrishnan, Emily L. McGinley, David G. Binion

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact

    The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact Por Nienke Z. Borren, Shadi Ghadermarzi, Susan Hutfless, Ashwin N. Ananthakrishnan

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: